WebDisclosure WebDisclosure
Basculer en Français
10965 Companies
240137 Keywords
168910 Articles
129233 Press releases
Headlines Articles Press releases ESGE Days 2026 Remove
  1. Home
  2. Companies
  3. ESGE Days 2026
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/15/2026 at 00:10, 3 months 28 days ago

    ESGE Days 2026: Endoscopic Procedure Surpasses Oral Semaglutide in Short-Term Weight Loss

    Weight Loss Clinical Study Obesity Treatment Endoscopic Sleeve Gastroplasty Oral Semaglutide
  • BRIEF

    published on 05/15/2026 at 00:10, 3 months 28 days ago

    ESGE Days 2026 : La procédure endoscopique surpasse le sémaglutide oral en matière de perte de poids à court terme

    Étude Clinique Perte De Poids Traitement De L'obésité Gastroplastie Endoscopique En Manchon Sémaglutide Oral
  • PRESS RELEASE

    published on 05/15/2026 at 00:05, 3 months 28 days ago

    ESGE Days 2026: Endoscopic procedure associated with greater short-term weight loss than oral semaglutide, study finds

    Study presented at ESGE Days 2026 shows greater short-term weight loss with endoscopic sleeve gastroplasty vs. oral semaglutide in adults with obesity
    Weight Loss Study Endoscopic Sleeve Gastroplasty Oral Semaglutide ESGE Days 2026
    Logo of ESGE Days 2026
Accesswire
  • Published on 09/12/2026 at 02:35, 10 hours 55 minutes ago

    Gamma Resources Announces Extension of Private Placement Closing Date

  • Published on 09/11/2026 at 23:00, 14 hours 30 minutes ago

    Rio Grande Resources Engages Machai Capital for Investor Outreach

  • Published on 09/11/2026 at 22:05, 15 hours 25 minutes ago

    Usha Resources Announces Leadership Transition

  • Published on 09/11/2026 at 21:25, 16 hours 5 minutes ago

    Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects

  • Published on 09/11/2026 at 17:00, 20 hours 30 minutes ago

    Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE
EQS Group
  • Published on 09/12/2026 at 07:30, 5 hours 59 minutes ago

    NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia

  • Published on 09/11/2026 at 22:15, 15 hours 15 minutes ago

    Amrize Appoints Mario Gross as President of Building Envelope

  • Published on 09/11/2026 at 22:10, 15 hours 19 minutes ago

    Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference

  • Published on 09/11/2026 at 19:44, 17 hours 45 minutes ago

    DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031

  • Published on 09/11/2026 at 18:15, 19 hours 14 minutes ago

    CGTN: How BRICS creates new opportunities for Global South development

View all EQS
Les Echos
  • Published on 09/11/2026 at 07:00, 1 day 6 hours ago

    Transparantiekennisgeving van Baltisse Groep

  • Published on 09/11/2026 at 07:00, 1 day 6 hours ago

    Transparency notification by Baltisse Group

  • Published on 09/11/2026 at 07:00, 1 day 6 hours ago

    BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY

  • Published on 09/11/2026 at 07:00, 1 day 6 hours ago

    BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ

  • Published on 09/10/2026 at 19:30, 1 day 18 hours ago

    Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy